The Norwood-Hamilton scale, often shortened to the Norwood scale, is the most widely used clinical system for staging male pattern hair loss. It was developed in the 1950s by James Hamilton and refined in the 1970s by O'Tar Norwood, and it remains the standard framework physicians and researchers use to describe progression of androgenetic alopecia in men.
This page walks through each stage, explains the typical progression patterns, and outlines when medical treatment is generally most effective.
What the Norwood scale describes
The Norwood scale categorizes male pattern hair loss along a progression from minimal recession to extensive baldness. It captures two main dimensions of progression:
- Frontal recession: backward movement of the hairline at the temples
- Vertex thinning: gradual loss at the crown
These two patterns often progress in parallel and eventually merge, although the rate and pattern vary between individuals.
The scale is descriptive rather than predictive. A person at any given stage will not necessarily progress further, and the rate of progression depends on age of onset, family history, and other factors. Earlier onset generally correlates with more advanced eventual loss.
The seven Norwood stages
Stage 1: no significant loss
Stage 1 represents a full or near-full hairline with no evidence of recession or crown thinning. This is the baseline against which subsequent progression is measured.
Stage 2: mild temple recession
The hairline begins to recede slightly at the temples, producing a subtle widow's peak shape. This is sometimes called a "mature hairline" and may not represent true androgenetic alopecia in all cases. A mature hairline is normal age-related change and stabilises; pattern hair loss continues to progress.
Distinguishing the two requires assessment of the rate of change, the symmetry of recession, and family history. Our receding hairline page covers this distinction in more depth.
Stage 3: clear hairline recession
At Stage 3, the recession at the temples becomes pronounced and unmistakable. The hairline has taken on a distinct M shape, and the recession typically extends well behind a line drawn from the top of one ear to the other.
A subtype, Stage 3 vertex, indicates simultaneous thinning at the crown alongside the temple recession. This is often the first stage at which crown loss is clinically apparent.
Stage 4: deeper recession with crown involvement
Stage 4 features:
- Significant frontal recession beyond Stage 3
- Visible thinning at the crown
- A band of hair separating the frontal and crown regions, which is still relatively dense
The horseshoe-shaped pattern of permanent hair around the back and sides remains intact and dense.
Stage 5: thinning band between front and crown
The band of hair separating the front and crown regions begins to thin and narrow. The frontal and vertex regions remain distinct but appear closer to merging. The horseshoe-shaped pattern around the sides and back is still preserved.
Stage 6: front and crown merging
The band of hair between the front and crown has thinned to the point where the two bald regions visually merge. A larger contiguous area of baldness is now present across the top of the scalp. The horseshoe pattern continues to provide stable hair on the back and sides.
Stage 7: extensive baldness
Stage 7 represents the most advanced stage on the scale. The top of the scalp shows extensive baldness, with hair remaining only in a narrow band around the sides and lower back. The remaining hair may itself appear sparser than in earlier stages, but it generally does not regress further because those follicles are largely DHT-resistant.
Less common variants
The standard Norwood scale captures the most typical progression patterns, but two variants are recognized:
- Norwood Type A variant: front-to-back progression without distinct crown thinning. The hairline recedes more uniformly and the crown is affected only later in the process.
- Diffuse pattern alopecia: a more even thinning across the top, less following the classic frontal and crown pattern. More common in some ethnic groups and in some women.
Why staging matters clinically
Understanding the stage of pattern hair loss informs several practical decisions:
Treatment expectations
Earlier stages respond more completely to medical treatment because more follicles are still active. By Stages 5-6, follicles in the bald regions have often been dormant for years and may not respond to medication, although the surrounding band of thinning hair can still benefit. By Stage 7, medical treatment primarily preserves what remains rather than restoring what is lost.
Treatment urgency
Progression rates vary, but patients at earlier stages generally have a wider window in which to halt or partially reverse loss. Each year of unchecked progression makes more reversal less likely.
Planning for hair restoration
For individuals considering surgical hair restoration, staging informs the realistic donor supply, the extent of coverage achievable, and the timing relative to medical stabilization.
Ruling out other causes
Loss that does not fit a recognizable Norwood pattern, particularly rapid diffuse loss, patchy loss, or loss accompanied by inflammation, may not be androgenetic alopecia and should be evaluated for other causes such as telogen effluvium, alopecia areata, or scarring alopecias.
When treatment is most effective
The general principle is straightforward: earlier intervention produces better outcomes. More specifically:
Stages 1-2
Often a question of monitoring. If there is family history of pattern hair loss, baseline photographs and periodic review can detect early progression. Active treatment may be considered if there is clear evidence of follicle miniaturization or accelerating thinning.
Stages 3-4
These stages are well-suited to medical treatment. Combination minoxidil and finasteride, when medically appropriate, has the strongest evidence base. Outcomes typically include stabilization plus visible thickening within 6-12 months of consistent use. The relevant medications are compared on our minoxidil vs finasteride page.
Stages 5-6
Treatment can still slow further progression and produce thickening in areas where follicles remain active, particularly the crown. Bald regions may be partially refilled, although complete restoration to a juvenile hairline is not a typical outcome with medication alone. Patients at these stages sometimes consider hair transplantation in combination with medical therapy.
Stage 7
Medical treatment at this stage primarily maintains the existing horseshoe pattern. Restoration of the bald top requires surgical intervention if the goal is renewed coverage. Continued medication remains relevant after transplantation to preserve non-transplanted areas.
These are general patterns and not predictive of any individual outcome. A physician's assessment is necessary to determine appropriate treatment for a given case.
How to identify your stage
For a self-assessment:
- Take photos in consistent lighting from the front, top, and crown
- Compare to images of the Norwood scale (widely available online)
- Note any asymmetry between sides
- Consider the rate of change over the past 12-24 months
Self-staging is an approximation. A physician can refine the assessment with trichoscopy and a structured history. For Curekey patients, photo evaluation is part of the standard online consultation process.
Treatment selection by stage
The medications most commonly used for androgenetic alopecia are minoxidil, finasteride, dutasteride (off-label), and adjunctive options such as microneedling. Treatment selection involves matching the intervention to the stage, the patient's medical history, and personal preferences.
Detailed comparisons are available on:
Considering medical assessment
Knowing the stage of pattern hair loss is a starting point. A complete assessment includes confirmation of the diagnosis, screening for contributing factors, and an individualized treatment plan. Curekey provides physician-led evaluation through a HIPAA-compliant telehealth process. Licensed U.S. physicians review each case and prescribe medications only when medically appropriate. Pharmacies fulfilling medications are licensed and follow standard regulatory practices. The process is described on our how it works page.
